IncFact
Company Profile: Revenue, Growth, Competition

SYROS PHARMACEUTICALS - Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 
VC / Private Equity
Venture Capital / Private Equity

Company Profile & Financial Information for Syros Pharmaceuticals

Access the complete profile.


Fast Facts

Revenue$10 - $50 million    Exact Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
541712
Address620 Memorial Drive Suite 300
Cambridge, MA 02139

Note: Revenues for privately held companies are statistical evaluations.


Syros Pharmaceuticals's Business Operations Profile shows critical firmographic facts:
  • What is the company's size? (Revenue and employees)
  • What industry is the company in?

Syros Pharmaceuticals Revenue and Growth Rate

Syros Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Syros Pharmaceuticals's revenues are gauged from an analysis of company filings.



Investor Activity

Syros Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
February 9, 2018 1 100%$11 MM
Complete list of funding rounds and total amounts in the Company Report




Syros Pharmaceuticals's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Syros Pharmaceuticals Revenue (Sales) Syros Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Syros Pharmaceuticals is developing and marketing. Syros Pharmaceuticals doesn't have any recent trademark applications, indicating Syros Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
SYROS
pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators
SYROS PHARMACEUTICALS
pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Syros Pharmaceuticals's intellectual property, its current capabilities and future direction. Syros Pharmaceuticals has applied for 6 patents since 2009. Syros Pharmaceuticals's most recent patent was filed in June 2017 for Inhibitors Of Cyclin-dependent Kinase 7 (cdk7). Array


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Syros Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Syros Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Syros Pharmaceuticals vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Syros Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
DYNAMIC PHARMACEUTICALSBrooksville, FL100 
NATURAL-IMMUNOGENICSSarasota, FL65 
VITALDYNEWaverly, MN45 
B&B HERBAL FUTURES INC. DBA OSandy, OR41 
PRIMA FLEUR BOTANICALSSan Rafael, CA29 
JASON PRATTE ENTERPRISESPhoenix, AZ22 




Nearby Competitors

These companies are similar in business line and location to Syros Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
BIOGEN U.S.Cambridge, MA100 
MILLENNIUM PHARMACEUTICALSCambridge, MA7 
INTARCIA THERAPEUTICSBoston, MA2 
ABCAMCambridge, MA2 
BRAINTREE LABORATORIESBraintree, MA1 
MERRIMACK PHARMACEUTICALSCambridge, MA1 




Similar Sized Companies near Cambridge

These are similar in size and location to Syros Pharmaceuticals.

Company HeadquartersRevenue ($ MM)
BEACON HOSPICECharlestown, MA99 
HERITAGE WHOLESALERSMalden, MA99 
RIEMER & BRAUNSTEINBoston, MA100 
GORDON BROTHERS GROUPBoston, MA100 
EVERETT MANAGEMENTEverett, MA100 
GEODE CAPITAL MANAGEMENTBoston, MA100 
FORMLABSSomerville, MA98 
NEW FRANCEBoston, MA98 
COMBINED JEWISH PHILANTHROPIESBoston, MA98 
PUBMARKCambridge, MA97 
WALNUT STREET CENTERMedford, MA97 
NIGHT SHIFT BREWINGEverett, MA97 




Fastest Growing Competitors

These companies are in the same general field as Syros Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Syros Pharmaceuticals Competitors